HOME >> BIOLOGY >> NEWS
What's shaped like a pear and has two genomes? Check the pond

Rockville, MD--If you could peer microscopically into the closest freshwater pond, you'd hesitate before dipping a toe. Amid the murky water, you'd probably notice an oddly furry, pear-shaped organism gliding along--and gobbling up everything in its path.

This tiny predator has a big name--Tetrahymena thermophila--and a big fan club among scientists, as a star organism for research into how cells work.

Scientists have now sequenced, assembled, and analyzed T. thermophila's macronuclear genome. Their work, reported in today's issue of Public Library of Science (PLoS) Biology, explains the organism's impressive versatility. Rather than dividing labor into several types of cells, as humans and other multicellular organisms do, T. thermophila divides its activities, either into different places inside a cell or by changing the cell over time. It is a master multi-tasker.

"This organism is a true generalist," says evolutionary biologist Jonathan A. Eisen, who led the Tetrahymena project while at The Institute for Genomic Research (TIGR) and is now at the University of California, Davis. "Whatever this unicell touches with its hairlike projections, it will try to eat. If it does not bump into anything, the organism will seek out food with diverse sensory systems. It can protect itself from radiation and other threats and also can fight back against competitors and predators. In short, versatility is its strength. Now, we can understand how this versatility works."

It takes plenty of genes. In fact, T. thermophila has roughly 25,000 genes--nearly as many as humans do. Although the organism is single-celled, it contains a genetic repertoire of seemingly more complex organisms. It shares, with humans and other animals, many genes and processes typically absent in single-celled organisms. That means Tetrahymena may be an ideal model organism for studies of the processes these genes encode.


'"/>

Contact: Kathryn Brown
kbrown@endpointcreative.biz
703-549-6641
The Institute for Genomic Research
28-Aug-2006


Page: 1 2 3

Related biology news :

1. Whats the backscatter of your beer?
2. Whats going on in the body? Advanced time-of-flight PET takes a superior look
3. Whats in the water? Estrogenic activity documented in fish caught in Pittsburghs rivers
4. A Cross-Disciplinary Look at Scientific Truth: Whats the Law to Do?
5. Whats the difference between mice and men?
6. Ossur repeats Popular Science Best of Whats New award
7. Whats next for gene therapy? Plastic
8. Whats nature worth? New computer models tell all
9. HPV Vaccine: Whats next
10. Anti-evolutionism in AmericaWhats ahead?
11. Ossurs Power Knee wins Popular Science magazines 2005 Best of Whats New Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: What shaped like pear and has two genomes Check the pond

(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
(Date:10/22/2014)... Involution Studios , a healthcare software ... infographic, Understanding Ebola . The goal of ... to follow informative tool for anyone wanting to know ... prevention. , "As the news has spread in all ... represents not only a healthcare crisis with global impact, ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... which brings Q3 orders to $5.8 million and provides a good ... in North America and one in the ... bid new projects at record levels," said Peter Bruijns , ... at the end of Q3 than they have been for any ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
Cached News: